LifeScience
ACROBiosystems Expands Global Licensing Access For HEK293 Functional Cell Lines
ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...
May 12, 2026 | News
Chance Pharma Advances First NDA Submission In China For Innovative Asthma Therapy CXG87
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...
May 11, 2026 | News
Rznomics Secures FDA RMAT Designation For RNA Editing Therapy RZ 001 In Liver Cancer
RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, ...
May 11, 2026 | News
Harbour BioMed Secures US FDA Clearance For Phase I Trial Of Bispecific Cancer Antibody HBM7004
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...
May 11, 2026 | News
ACROBiosystems Simplifies Global HEK293 Licensing To Accelerate Biopharma R&D Compliance
ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrat...
May 11, 2026 | News
Cartography Biosciences Secures Strategic Investment From Samsung Ventures To Advance Precision Oncology Pipeline
Cartography Biosciences and Samsung Ventures announced a strategic investment to support the advancement of Cartography’s differentiated oncology pip...
May 08, 2026 | News
Ribo And Boehringer Ingelheim Reach Third Milestone In siRNA Collaboration Targeting MASH Therapies
Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) announced the achievement of a further milestone. This marks the th...
May 08, 2026 | News
Ribbon Bio Launches Cell Free DNA Platform And In House MiroMine Kit To Expand Access To Complex Synthetic DNA
Ribbon's launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMi...
May 07, 2026 | News
Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing
New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical productio...
May 05, 2026 | News
EnGeneIC Doses First Patient In Trial Targeting Recurrent Glioblastoma
EnGeneIC announced that the first patient has been dosed in its clinical trial evaluating EnGeneIC’s investigational EGFR-targeted EDV™ (EnGene...
May 05, 2026 | News
Sonire Therapeutics Initiates SUNRISE II Trial To Advance Non Invasive HIFU Therapy For Pancreatic Cancer In The United States
SUNRISE-II feasibility trial marks the company's entry into U.S. clinical development, advancingminimally invasive, anesthesia-free treatment approach Son...
May 04, 2026 | News
Henlius And Organon Secure European Approval For First Pertuzumab Biosimilar POHERDY
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHE...
May 01, 2026 | News
ACROBiosystems And SeromYx Partner To Advance Functional Profiling Of Anti CD20 Antibodies
ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collabora...
May 01, 2026 | News
Chongqing Claruvis Pharmaceutical Secures NMPA Approval For Retoxin As First Recombinant Botulinum Toxin
Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin&re...
April 30, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
